Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors

Published:2023-10 Issue: Volume:204 Page:151-158
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Pierce Jacob B.,Blumer Vanessa,Choi Sujung,Hardy N. Chantelle,Greiner Melissa A.,Carnicelli Anthony P.,Shen Xian,Lippmann Steven J.,Peterson Pamela N.,Allen Larry A.,Fonarow Gregg C.,Mentz Robert J.,Greene Stephen J.,O'Brien Emily C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. The vulnerable phase after hospitalization for heart failure;Greene;Nat Rev Cardiol,2015

2. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes;Shah;J Am Coll Cardiol,2017

3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

4. Comparative effectiveness of Sacubitril-Valsartan versus ACE/ARB therapy in heart failure with reduced ejection fraction;Tan;JACC Heart Fail,2020

5. Angiotensin-neprilysin inhibition in acute decompensated heart failure;Velazquez;N Engl J Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP